Occudo Quantitative Strategies LP Cure Vac N.V. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.94 - $4.34 $83,075 - $122,635	28,257 Added 184.89%	43,540 $131,000
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $60,520 - $97,964	15,283 New	15,283 $64,000
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $366,774 - $747,278	49,034 New	49,034 $386,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $698,487 - $1.03 Million	-52,996 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $780,631 - $1.87 Million	52,996 New	52,996 $1.04 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.